Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996-2004
about
Drug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohortsOutcomes of antiretroviral therapy in Vietnam: results from a national evaluationMortality, Causes of Death and Associated Factors Relate to a Large HIV Population-Based CohortIncreases in CD4+ T-cell count at antiretroviral therapy initiation among HIV-positive illicit drug users during a treatment-as-prevention initiative in Canada.Increasing late diagnosis in HIV infection in South Korea: 2000-2007.Late presenters to HIV care and treatment, identification of associated risk factors in HIV-1 infected Indian population.Introducing rapid oral-fluid HIV testing among high risk populations in Shandong, China: feasibility and challenges.Using syndemic theory to understand vulnerability to HIV infection among Black and Latino men in New York City.The relationship between injection and noninjection drug use and HIV disease progression.The Demand for Antiretroviral Drugs in the Illicit Marketplace: Implications for HIV Disease Management Among Vulnerable PopulationsEpidemiological characteristics and predictors of late presentation of HIV infection in Barcelona (Spain) during the period 2001-2009.The HIV care cascade: models, measures and moving forwardEarly antiretroviral therapy for patients with acute aids-related opportunistic infections: a cost-effectiveness analysis of ACTG A5164The urgency of providing comprehensive and integrated treatment for substance abusers with HIVFemale and male differences in AIDS diagnosis rates among people who inject drugs in large U.S. metro areas from 1993 to 2007.Late presentation to HIV/AIDS testing, treatment or continued care: clarifying the use of CD4 evaluation in the consensus definition.Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: a survey of North American HIV providers.A qualitative study of barriers to and facilitators of optimal engagement in care among PLWH and substance use/misuse.Uptake of Community-Based Peer Administered HIV Point-of-Care Testing: Findings from the PROUD Study.High Initial HIV/AIDS-Related Mortality and -Its Predictors among Patients on Antiretroviral Therapy in the Kagera Region of Tanzania: A Five-Year Retrospective Cohort StudyRacialized risk environments in a large sample of people who inject drugs in the United States.Late HIV Testing in a Cohort of HIV-Infected Patients in Puerto Rico.Methadone maintenance treatment and mortality in HIV-positive people who inject opioids in ChinaThe problem of late ART initiation in Sub-Saharan Africa: a transient aspect of scale-up or a long-term phenomenon?Rural AIDS diagnoses in Florida: changing demographics and factors associated with survival.Pharmacy staff characteristics associated with support for pharmacy-based HIV testingHIV disease progression to CD4 count <200 cells/μL and death in Saskatoon, Saskatchewan.Mixed method approach for determining factors associated with late presentation to HIV/AIDS care in southern India.Impact of supervised drug consumption services on access to and engagement with care at a palliative and supportive care facility for people living with HIV/AIDS: a qualitative study.Persistent racial/ethnic disparities in AIDS diagnosis rates among people who inject drugs in U.S. metropolitan areas, 1993-2007.Immunosuppressive effects of opioids--clinical relevance.The paradigm of universal access to HIV-treatment and human rights violation: how do we treat HIV-positive people who use drugs?Substance Use, Violence, and Antiretroviral Adherence: A Latent Class Analysis of Women Living with HIV in Canada.Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortality.Are there differences in disease progression and mortality among male and female HIV patients on antiretroviral therapy? A meta-analysis of observational cohorts.Mortality Risk After AIDS-Defining Opportunistic Illness Among HIV-Infected Persons--San Francisco, 1981-2012.Short-term additional enfuvirtide therapy is associated with a greater immunological recovery in HIV very late presenters: a controlled pilot study.Epidemiology of HIV among Asians and Pacific Islanders in the United States, 2001-2008.First presentation for care of HIV-infected patients with low CD4 cell count in Lyon, France: risk factors and consequences for survival.Late HIV diagnosis in Houston/Harris County, Texas, 2000-2007.
P2860
Q28477883-5BD0908E-FE48-4A86-8F10-BDC03FADDF8BQ28486180-5EA68BDC-D46D-4AEA-BB10-7C9D7DAFC445Q28551895-048D82D6-A712-49C7-A825-D674455B72C0Q30399058-B77041E7-D245-4AC2-90ED-D2275A261638Q33630884-00E43AB2-C8B0-4193-A8BC-B9C5D6BF146CQ33631762-EFEBB961-F563-40C4-B394-5FC192B8860FQ33712208-3BA9EFB4-E7BF-424F-918B-96E8CCA2B242Q34350603-22A141B7-9BC2-46CC-A552-7BBFD5AEB13FQ35032433-37867BFA-E323-4CBB-A3E1-1539EBAAA6BAQ35054628-B312834D-F2AD-41C6-AE34-5F57E0B08CB0Q35128754-532E4A95-C36E-4556-BF02-DAF02D4DBA95Q35143562-C1850756-5218-4524-937C-D8ABE66C2D8EQ35244295-46053BF8-0B02-4B22-825F-BF01DABCD43EQ35308404-21EB790D-F45C-4A1C-B1D0-6867D71729DAQ35751758-B983A82F-1747-49D7-A4FF-C4B1B0804713Q35770832-7FF21FB6-77B3-4F6D-911A-B3B6266FF3DBQ35835854-9FB7995E-34BA-408F-8E42-E068B6CA3E01Q35996628-8A913047-88EA-4695-8B1E-EC39FF600E1CQ36211866-1553580D-6244-4DA0-A425-2A2F770C02F9Q36220774-182ED5B2-2526-412E-9F9E-8613718113A5Q36471364-EDFA6E06-6352-478D-B8FF-3C5E8218F47BQ36645915-19C4D9FF-496B-4856-989E-E2E601DC2440Q36706986-6CA540E8-0CDD-445C-A789-99DAAA12A36EQ36848380-6C6E41DC-3C06-4C85-8EC4-BCE115473DC8Q36962851-6FA88348-7497-4E1B-8AC0-734BCE2AC2ABQ36989911-F0C9DA7A-DD25-4BB6-AE76-07918E322751Q37037327-E81FBF25-A2FD-4970-ACF7-964DFADF5831Q37145957-EBD46C07-979F-42DD-833C-869ED2562E6BQ37640091-5930D88E-BBC5-48E9-9AB1-862920C904B9Q37696114-F03656F9-E047-4AAE-B925-FA443AEACF71Q37897497-CCC31B3C-F022-40D8-AF3F-C1461EB24DDFQ38173892-C4E43D87-B9A3-40EF-886C-0A320FA71274Q40124137-8F49BF73-C913-4F92-BB9D-8DAFFE59D14EQ40786609-757D84EC-4AE4-4906-AF84-F3C7E208BA67Q40860723-896B246A-8814-4A36-B752-D3755608B147Q40868698-510697FA-11E4-4895-BF56-E9D72317076CQ42627139-5F6DAC80-91AF-47E4-80BD-520D4486FE26Q45001306-C1CFE711-85BA-4EBD-A414-4D0B1AAC05F8Q45376543-569827E1-DF33-4D66-8FDC-9274F8C79B32Q46063550-7EE8DF95-44CC-487D-A343-9DBC222716AB
P2860
Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996-2004
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Late HIV diagnosis and determi ...... users, 33 US States, 1996-2004
@ast
Late HIV diagnosis and determi ...... users, 33 US States, 1996-2004
@en
Late HIV diagnosis and determi ...... users, 33 US States, 1996-2004
@nl
type
label
Late HIV diagnosis and determi ...... users, 33 US States, 1996-2004
@ast
Late HIV diagnosis and determi ...... users, 33 US States, 1996-2004
@en
Late HIV diagnosis and determi ...... users, 33 US States, 1996-2004
@nl
prefLabel
Late HIV diagnosis and determi ...... users, 33 US States, 1996-2004
@ast
Late HIV diagnosis and determi ...... users, 33 US States, 1996-2004
@en
Late HIV diagnosis and determi ...... users, 33 US States, 1996-2004
@nl
P2093
P2860
P921
P3181
P1433
P1476
Late HIV diagnosis and determi ...... users, 33 US States, 1996-2004
@en
P2093
Anna Grigoryan
H Irene Hall
Tonji Durant
Xiangming Wei
P2860
P3181
P356
10.1371/JOURNAL.PONE.0004445
P407
P577
2009-01-01T00:00:00Z